Log in

NYSE:WAT - Waters Stock Price, Forecast & News

$232.37
-5.16 (-2.17 %)
(As of 01/28/2020 06:00 AM ET)
Today's Range
$231.72
Now: $232.37
$236.06
50-Day Range
$226.32
MA: $233.64
$244.09
52-Week Range
$199.11
Now: $232.37
$255.21
Volume523,734 shs
Average Volume475,066 shs
Market Capitalization$14.97 billion
P/E Ratio28.62
Dividend YieldN/A
Beta1.04
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. Read More…

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
CUSIP94184810
Phone508-478-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.42 billion
Cash Flow$9.71 per share
Book Value$20.69 per share

Profitability

Net Income$593.79 million

Miscellaneous

Employees7,200
Market Cap$14.97 billion
Next Earnings Date2/4/2020 (Confirmed)
OptionableOptionable

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.


Waters (NYSE:WAT) Frequently Asked Questions

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

How will Waters' stock buyback program work?

Waters announced that its Board of Directors has authorized a share repurchase plan on Tuesday, April 24th 2018, which authorizes the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 18.2% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's board of directors believes its stock is undervalued.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) released its earnings results on Tuesday, October, 29th. The medical instruments supplier reported $2.13 earnings per share for the quarter, meeting the Zacks' consensus estimate of $2.13. The medical instruments supplier had revenue of $577.28 million for the quarter, compared to analyst estimates of $588.35 million. Waters had a net margin of 23.98% and a return on equity of 77.73%. Waters's revenue was down .1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.92 EPS. View Waters' Earnings History.

When is Waters' next earnings date?

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Waters.

How can I listen to Waters' earnings call?

Waters will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for WAT?

11 analysts have issued twelve-month target prices for Waters' shares. Their forecasts range from $177.00 to $230.00. On average, they expect Waters' stock price to reach $203.71 in the next year. This suggests that the stock has a possible downside of 12.3%. View Analyst Price Targets for Waters.

What is the consensus analysts' recommendation for Waters?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Waters.

Has Waters been receiving favorable news coverage?

News coverage about WAT stock has trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Waters earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Waters.

Are investors shorting Waters?

Waters saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 5,780,000 shares, an increase of 5.7% from the December 31st total of 5,470,000 shares. Based on an average trading volume of 444,600 shares, the days-to-cover ratio is currently 13.0 days. Approximately 9.0% of the shares of the company are short sold. View Waters' Current Options Chain.

Who are some of Waters' key competitors?

What other stocks do shareholders of Waters own?

Who are Waters' key executives?

Waters' management team includes the folowing people:
  • Christopher James O'Connell, Chairman & CEO (Age 52)
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 52)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 55)
  • Mr. Francis S. Kim, Sr. VP of Global Operations (Age 52)
  • Mr. Robert G. Carson, Sr. VP of Corp. Devel. & Interim Pres of TA Bus. (Age 45)

Who are Waters' major shareholders?

Waters' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Marathon Asset Management LLP (0.66%), Boston Trust Walden Corp (0.45%), Bristol John W & Co. Inc. NY (0.43%), Anchor Capital Advisors LLC (0.40%), California Public Employees Retirement System (0.25%) and Fenimore Asset Management Inc. (0.18%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Edward Conard, Elizabeth B Rae, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Institutional Ownership Trends for Waters.

Which institutional investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including Fenimore Asset Management Inc., Assenagon Asset Management S.A., Marathon Asset Management LLP, Copper Rock Capital Partners LLC, Mountain Pacific Investment Advisers Inc. ID, Nisa Investment Advisors LLC, New York State Teachers Retirement System and Boston Trust Walden Corp. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

Which institutional investors are buying Waters stock?

WAT stock was acquired by a variety of institutional investors in the last quarter, including Anchor Capital Advisors LLC, California Public Employees Retirement System, Campbell & CO Investment Adviser LLC, Nicolet Bankshares Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Birch Capital Management LLC, Douglass Winthrop Advisors LLC and Diversified Trust Co. View Insider Buying and Selling for Waters.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $232.37.

How big of a company is Waters?

Waters has a market capitalization of $14.97 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

What is Waters' official website?

The official website for Waters is http://www.waters.com/.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]


MarketBeat Community Rating for Waters (NYSE WAT)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  400 (Vote Outperform)
Underperform Votes:  550 (Vote Underperform)
Total Votes:  950
MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel